ORBIMED ADVISORS LLC Q4 2017 Filing

Filed February 14, 2018

Portfolio Value

$7.9B

Holdings

130

Report Date

Q4 2017

Filing Type

13F-HR

All Holdings (130 positions)

#StockSharesValue% PortfolioType
101
AMEDAMEDISYS INC
207,500$10.9B138.34%
102
NOVUS THERAPEUTICS INC
2,537,110$10.3B130.30%
103
FLBFLUIDIGM CORP DEL
1,583,700$9.3B117.99%
104
BMRNBIOMARIN PHARMACEUTICAL INC
100,600$9.0B113.47%
105
SRPTSAREPTA THERAPEUTICS INC
149,400$8.3B105.15%Call
106
LAB 2.75 02/01/34FLUIDIGM CORP DEL
10,000,000$8.3B105.01%
107
KIDSORTHOPEDIATRICS CORP
425,200$8.2B103.22%
108
AUPHAURINIA PHARMACEUTICALS INC
1,797,400$8.1B102.99%
109
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
1,469,524$8.0B100.56%
110
ENDO INTL PLC
1,024,386$7.9B100.42%
111
ALKSALKERMES PLC
145,000$7.9B100.38%
112
INOTEK PHARMACEUTICALS CORP
7,000,000$5.9B74.86%
113
GW PHARMACEUTICALS PLC
44,400$5.9B74.14%
114
TESARO INC
67,281$5.6B70.53%
115
MARINUS PHARMACEUTICALS INC
567,600$4.6B58.59%
116
PRQRPROQR THRAPEUTICS N V
1,302,955$4.2B53.15%
117
SNDXSYNDAX PHARMACEUTICALS INC
437,000$3.8B48.42%
118
RDHLGBPREDHILL BIOPHARMA LTD
564,900$2.9B36.73%
119
MCRB1EURSERES THERAPEUTICS INC
219,458$2.2B28.14%
120
XENEXENON PHARMACEUTICALS INC
634,812$1.8B22.68%
121
OREXIGEN THERAPEUTICS INC
5,210,000$1.8B22.60%
122
BHCVALEANT PHARMACEUTICALS INTL
76,800$1.6B20.19%
123
BIOLINERX LTD
1,038,600$1.1B14.32%
124
BIOMARIN PHARMACEUTICAL INC
500,000$594.0M7.51%
125
BIOMARIN PHARMACEUTICAL INC
500,000$540.0M6.83%
126
AFFIMED N V
326,650$425.0M5.38%
127
ALIMERA SCIENCES INC
250,000$333.0M4.21%
128
NOVELION THERAPEUTICS INC
100,000$312.0M3.95%
129
XTANT MED HLDGS INC
4,754,386$272.0M3.44%
130
MEDIGUS LTD
60,000$79.0M1.00%
PreviousPage 2 of 2